Drug Details
Therapeutic Class:
Glucagon-like peptide-1 (GLP-1) receptor agonists
Forms:
Oral tablet
Administration:
By mouth
Therapeutic Uses:
To improve glycemic control and lower blood glucose levels in adults with type 2 diabetes mellitus
Controlled Status:
Not a controlled substance
Rybelsus Drug Class
Rybelsus (rai-bel-sus) belongs to a group of medications called glucagon-like peptide-1 (GLP-1) receptor agonists.
Rybelsus Age Range
Rybelsus (semaglutide) is approved for use in adults. The safety and effectiveness of Rybelsus have not been established in pediatric patients younger than 18 years of age.
SOCIAL